Search structured details from individual public forum accounts. These are anecdotes, not clinical evidence or estimates of how often an outcome occurs.
Only curator-approved records with a currently verified source appear here. No usernames or copied post bodies are published.
A first-person SMILE account at 1 year described the result. Topics included dry eye. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account at 2 months described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included dry eye, starbursts, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included dry eye, blur or fluctuating vision, haze. The poster's overall assessment was favorable.
A first-person SMILE account at 4 weeks described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/60, 20/40. Topics included dry eye, halos, blur or fluctuating vision. The poster described a mixed result or a recovery with meaningful tradeoffs.
A first-person SMILE account at 25 days described the result. The source included baseline prescription values. Reported acuity included 10/10, 20/20. Topics included dry eye, halos, starbursts, blur or fluctuating vision. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included blur or fluctuating vision. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account with a postoperative follow-up described the result. Reported acuity included 20/150, 6/10, 6/11, 20/25. Topics included blur or fluctuating vision, light sensitivity, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/15. Topics included dry eye, halos, starbursts, glare. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. Reported acuity included 20/11, 20/13, 20/10. Topics included dry eye, ghosting, blur or fluctuating vision. The poster's overall assessment was unfavorable.
A first-person SMILE account at 3 weeks described the result. Reported acuity included 20/20. Topics included ghosting, double vision. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account at 3 months described the result. Reported acuity included 20/20. Topics included dry eye, pain or discomfort. The poster's overall assessment was favorable.
A first-person SMILE account at 6 months described the result. The source included baseline prescription values. Topics included dry eye, blur or fluctuating vision, regression. The poster described a mixed result or a recovery with meaningful tradeoffs.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20. Topics included halos, starbursts, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. Reported acuity included 6/24. Topics included haze, pain or discomfort. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 6/3, 6/2, 6/4, 6/5. Topics included dry eye, blur or fluctuating vision, light sensitivity, pain or discomfort. The poster described a mixed result or a recovery with meaningful tradeoffs.
A first-person SMILE account at 2 weeks described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/25. Topics included dry eye, halos, glare, blur or fluctuating vision. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. Reported acuity included 20/20. Topics included glare. The poster's overall assessment was favorable.
A first-person SMILE account at 10 days described the result. The source included baseline prescription values. Topics included dry eye, blur or fluctuating vision. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account at 3 months described the result. Reported acuity included 20/20. The source did not state a clear overall satisfaction judgment.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Topics included light sensitivity. The poster's overall assessment was favorable.
A first-person SMILE account at 1.5 months described the result. Reported acuity included 20/20. Topics included starbursts, glare, blur or fluctuating vision, haze. The poster described a mixed result or a recovery with meaningful tradeoffs.
After high-prescription SMILE, the poster reached 20/20 on day one but experienced second-week corneal swelling, transient morning blur and later clinically evident dryness. At one month binocular vision remained 20/20 and the poster was still satisfied.
A first-person SMILE account at 3 days described the result. Reported acuity included 20/20, 20/15. Topics included halos, light sensitivity, pain or discomfort. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. The source explicitly reported pre-existing dry eye. Reported acuity included 20/25, 20/20, 20/16. Topics included dry eye, glare, blur or fluctuating vision, pain or discomfort. The poster's overall assessment was favorable.
A first-person SMILE account with a postoperative follow-up described the result. The source included baseline prescription values. Reported acuity included 20/20, 20/50, 20/200, 20/63. Topics included dry eye, double vision, pain or discomfort. The poster's overall assessment was favorable.